{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:37:19Z","timestamp":1792791439254,"version":"4.5.0"},"reference-count":115,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Immunology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.smim.2026.102026","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T11:49:44Z","timestamp":1776340184000},"page":"102026","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Novel therapeutic strategies leveraging TH9 cell anticancer functions"],"prefix":"10.1016","volume":"82","author":[{"given":"Jiazhi","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souleymane","family":"Abdoul-Azize","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2774-438X","authenticated-orcid":false,"given":"Lionel","family":"Apetoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.smim.2026.102026_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4049\/jimmunol.153.9.3989","article-title":"IL-9 production of naive CD4+ T cells depends on IL-2, is synergistically enhanced by a combination of TGF-beta and IL-4, and is inhibited by IFN-gamma","volume":"153","author":"Schmitt","year":"1994","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.smim.2026.102026_bib2","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1002\/eji.1830191130","article-title":"TCGF III\/P40 is produced by naive murine CD4+ T cells but is not a general T cell growth factor","volume":"19","author":"Schmitt","year":"1989","journal-title":"Eur. J. Immunol."},{"issue":"12","key":"10.1016\/j.smim.2026.102026_bib3","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/ni.1677","article-title":"IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells","volume":"9","author":"Dardalhon","year":"2008","journal-title":"Nat. Immunol."},{"issue":"12","key":"10.1016\/j.smim.2026.102026_bib4","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ni.1659","article-title":"Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset","volume":"9","author":"Veldhoen","year":"2008","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.smim.2026.102026_bib5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/ni.1867","article-title":"The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation","volume":"11","author":"Chang","year":"2010","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.smim.2026.102026_bib6","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.immuni.2005.03.016","article-title":"PU.1 expression delineates heterogeneity in primary Th2 cells","volume":"22","author":"Chang","year":"2005","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.smim.2026.102026_bib7","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/ni.2133","article-title":"An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation","volume":"12","author":"Wilhelm","year":"2011","journal-title":"Nat. Immunol."},{"issue":"11","key":"10.1016\/j.smim.2026.102026_bib8","doi-asserted-by":"crossref","first-page":"7169","DOI":"10.4049\/jimmunol.0901906","article-title":"Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes","volume":"183","author":"Jager","year":"2009","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.smim.2026.102026_bib9","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1172\/JCI65459","article-title":"Th9 cells promote antitumor immune responses in vivo","volume":"122","author":"Lu","year":"2012","journal-title":"J. Clin. Invest"},{"issue":"8","key":"10.1016\/j.smim.2026.102026_bib10","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/ni.2925","article-title":"The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells","volume":"15","author":"Vegran","year":"2014","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2026.102026_bib11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00281-016-0599-4","article-title":"T(H)9 cells in anti-tumor immunity","volume":"39","author":"Rivera Vargas","year":"2017","journal-title":"Semin Immunopathol."},{"issue":"1","key":"10.1016\/j.smim.2026.102026_bib12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00281-016-0600-2","article-title":"The transcription factor network in Th9 cells","volume":"39","author":"Kaplan","year":"2017","journal-title":"Semin Immunopathol."},{"issue":"5","key":"10.1016\/j.smim.2026.102026_bib13","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nri3824","article-title":"The development and in vivo function of T helper 9 cells","volume":"15","author":"Kaplan","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.smim.2026.102026_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2025.101999","article-title":"Three's company: The cooperative signals behind the differentiation of Th9 cells","volume":"80","author":"Rodriguez","year":"2025","journal-title":"Semin Immunol."},{"key":"10.1016\/j.smim.2026.102026_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2026.102017","article-title":"Emerging roles of IL-9 and Th9 cells in respiratory viral illnesses","volume":"81","author":"Dandotiya","year":"2026","journal-title":"Semin Immunol."},{"key":"10.1016\/j.smim.2026.102026_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2026.102014","article-title":"Diverse IL-9-secreting T helper cells direct responses in the allergic lung","volume":"81","author":"Jackson","year":"2026","journal-title":"Semin Immunol."},{"key":"10.1016\/j.smim.2026.102026_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2025.102013","article-title":"New insights into Th9 cells in inflammatory bowel diseases","volume":"81","author":"Neurath","year":"2026","journal-title":"Semin Immunol."},{"key":"10.1016\/j.smim.2026.102026_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2025.102003","article-title":"T(H)9 cells and interleukin-9 in parasitic infections: Updates, opportunities, and challenges","volume":"80","author":"Orozco-Cordoba","year":"2025","journal-title":"Semin Immunol."},{"key":"10.1016\/j.smim.2026.102026_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2025.101979","article-title":"Uncovered role of Th9 and IL-9 in rheumatoid arthritis: Current status and future directions","volume":"79","author":"Tu","year":"2025","journal-title":"Semin Immunol."},{"issue":"8","key":"10.1016\/j.smim.2026.102026_bib20","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/nm.2856","article-title":"Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells","volume":"18","author":"Purwar","year":"2012","journal-title":"Nat. Med"},{"issue":"12","key":"10.1016\/j.smim.2026.102026_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009629","article-title":"Natural lung-tropic T(H)9 cells: a sharp weapon for established lung metastases","volume":"12","author":"Chen","year":"2024","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.smim.2026.102026_bib22","doi-asserted-by":"crossref","first-page":"5902","DOI":"10.1038\/s41467-020-19672-2","article-title":"Enhanced CAR-T activity against established tumors by polarizing human T cells to secrete interleukin-9","volume":"11","author":"Liu","year":"2020","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.smim.2026.102026_bib23","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.ccell.2021.09.011","article-title":"Adoptive cell therapy with tumor-specific Th9 cells induces viral mimicry to eliminate antigen-loss-variant tumor cells","volume":"39","author":"Xue","year":"2021","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.smim.2026.102026_bib24","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.4049\/jimmunol.1301276","article-title":"Smad2\/3 and IRF4 play a cooperative role in IL-9-producing T cell induction","volume":"191","author":"Tamiya","year":"2013","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.smim.2026.102026_bib25","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/eji.201546061","article-title":"IL-9 promotes the survival and function of human melanoma-infiltrating CD4(+) CD8(+) double-positive T cells","volume":"46","author":"Parrot","year":"2016","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.smim.2026.102026_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1509408","article-title":"Regulation of human Th9 cell differentiation by lipid modulators targeting PPAR-\u03b3 and acetyl-CoA-carboxylase 1","volume":"15","author":"Peesari","year":"2024","journal-title":"Front Immunol."},{"issue":"7","key":"10.1016\/j.smim.2026.102026_bib27","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.jid.2024.10.616","article-title":"Human T Helper 9 Cells Rely on Peroxisome Proliferator-Activated Receptor-\u03b3-Mediated Cystine Uptake to Prevent Lipid Peroxidation and Bioenergetic Failure","volume":"145","author":"Bazzini","year":"2025","journal-title":"J. Invest Dermatol."},{"issue":"8","key":"10.1016\/j.smim.2026.102026_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114565","article-title":"MicroRNA-19b exacerbates systemic sclerosis through promoting Th9 cells","volume":"43","author":"Lim","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.smim.2026.102026_bib29","article-title":"Inborn errors of immunity reveal molecular requirements for generation and maintenance of human CD4(+) IL-9-expressing cells","author":"Rao","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"issue":"35","key":"10.1016\/j.smim.2026.102026_bib30","article-title":"Transcription Factor Id1 Plays an Essential Role in Th9 Cell Differentiation by Inhibiting Tcf3 and Tcf4","volume":"10","author":"Lee","year":"2023","journal-title":"Adv. Sci. (Weinh. )"},{"issue":"1","key":"10.1016\/j.smim.2026.102026_bib31","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1038\/s41467-023-38233-x","article-title":"PPAR-\u03b3 regulates the effector function of human T helper 9 cells by promoting glycolysis","volume":"14","author":"Bertschi","year":"2023","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.smim.2026.102026_bib32","doi-asserted-by":"crossref","first-page":"968","DOI":"10.4049\/jimmunol.1102840","article-title":"STAT6-dependent regulation of Th9 development","volume":"188","author":"Goswami","year":"2012","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2026.102026_bib33","doi-asserted-by":"crossref","first-page":"198","DOI":"10.4049\/jimmunol.1303184","article-title":"BCL6 controls Th9 cell development by repressing Il9 transcription","volume":"193","author":"Bassil","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2026.102026_bib34","doi-asserted-by":"crossref","first-page":"10857","DOI":"10.1038\/ncomms10857","article-title":"Itk is required for Th9 differentiation via TCR-mediated induction of IL-2 and IRF4","volume":"7","author":"Gomez-Rodriguez","year":"2016","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.smim.2026.102026_bib35","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/ni.3252","article-title":"The DNA-binding inhibitor Id3 regulates IL-9 production in CD4(+) T cells","volume":"16","author":"Nakatsukasa","year":"2015","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.smim.2026.102026_bib36","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.ccell.2018.05.004","article-title":"Th9 Cells Represent a Unique Subset of CD4(+) T Cells Endowed with the Ability to Eradicate Advanced Tumors","volume":"33","author":"Lu","year":"2018","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.smim.2026.102026_bib37","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.immuni.2016.05.009","article-title":"Histone Deacetylase SIRT1 Negatively Regulates the Differentiation of Interleukin-9-Producing CD4(+) T Cells","volume":"44","author":"Wang","year":"2016","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.smim.2026.102026_bib38","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.4049\/jimmunol.1201496","article-title":"Gcn5 is required for PU.1-dependent IL-9 induction in Th9 cells","volume":"189","author":"Goswami","year":"2012","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.smim.2026.102026_bib39","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20202144","article-title":"BFAR coordinates TGF\u03b2 signaling to modulate Th9-mediated cancer immunotherapy","volume":"218","author":"Pei","year":"2021","journal-title":"J. Exp. Med"},{"issue":"1","key":"10.1016\/j.smim.2026.102026_bib40","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.1038\/s41467-022-33733-8","article-title":"Opposing functions of circadian protein DBP and atypical E2F family E2F8 in anti-tumor Th9 cell differentiation","volume":"13","author":"Park","year":"2022","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.smim.2026.102026_bib41","doi-asserted-by":"crossref","first-page":"823","DOI":"10.4049\/jimmunol.2300635","article-title":"Activin A Promotes Differentiation of a Pathogenic Multicytokine IL-9-secreting CD4+ T Cell Population","volume":"213","author":"Ulrich","year":"2024","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2026.102026_bib42","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/s41467-017-00674-6","article-title":"Transcription factor Foxo1 is essential for IL-9 induction in T helper cells","volume":"8","author":"Malik","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2026.102026_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2021.101477","article-title":"Harnessing T(H)9 cells in cancer immunotherapy","volume":"52","author":"Benoit-Lizon","year":"2021","journal-title":"Semin Immunol."},{"issue":"1","key":"10.1016\/j.smim.2026.102026_bib44","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40425-018-0494-8","article-title":"TNF-\u03b1 enhances Th9 cell differentiation and antitumor immunity via TNFR2-dependent pathways","volume":"7","author":"Jiang","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.smim.2026.102026_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1032618","article-title":"IL-1\u03b2 promotes IL-9-producing Th cell differentiation in IL-2-limiting conditions through the inhibition of BCL6","volume":"13","author":"Canaria","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.smim.2026.102026_bib46","article-title":"Interferon-\u03b3 Stimulates Interleukin-27 Derived from Dendritic Cells to Regulate Th9 Differentiation through STAT1\/3 Pathway","author":"Xiong","year":"2022","journal-title":"Dis. Markers 2022"},{"issue":"9","key":"10.1016\/j.smim.2026.102026_bib47","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/eji.201646846","article-title":"Toll like Receptor 2 engagement on CD4(+) T cells promotes TH9 differentiation and function","volume":"47","author":"Karim","year":"2017","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2026.102026_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.115136","article-title":"Mechanical force receptor Piezo1 regulates T(H)9 cell differentiation","volume":"44","author":"Yang","year":"2025","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.smim.2026.102026_bib49","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1038\/s41467-021-23042-x","article-title":"EGFR-HIF1\u03b1 signaling positively regulates the differentiation of IL-9 producing T helper cells","volume":"12","author":"Roy","year":"2021","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.smim.2026.102026_bib50","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1073\/pnas.1317431111","article-title":"Tumor-specific IL-9-producing CD8+ Tc9 cells are superior effector than type-I cytotoxic Tc1 cells for adoptive immunotherapy of cancers","volume":"111","author":"Lu","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.smim.2026.102026_bib51","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1038\/s41467-019-10889-4","article-title":"Fas signaling-mediated T(H)9 cell differentiation favors bowel inflammation and antitumor functions","volume":"10","author":"Shen","year":"2019","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.smim.2026.102026_bib52","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/nm.3922","article-title":"Glucocorticoid-induced tumor necrosis factor receptor-related protein co-stimulation facilitates tumor regression by inducing IL-9-producing helper T cells","volume":"21","author":"Kim","year":"2015","journal-title":"Nat. Med"},{"issue":"4","key":"10.1016\/j.smim.2026.102026_bib53","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/ijc.30121","article-title":"Induction of antigen-specific TH 9 immunity accompanied by mast cell activation blocks tumor cell engraftment","volume":"139","author":"Abdul-Wahid","year":"2016","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.smim.2026.102026_bib54","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.intimp.2017.08.031","article-title":"Th9 cells promote antitumor immunity via IL-9 and IL-21 and demonstrate atypical cytokine expression in breast cancer","volume":"52","author":"You","year":"2017","journal-title":"Int Immunopharmacol."},{"issue":"3","key":"10.1016\/j.smim.2026.102026_bib55","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1158\/2326-6066.CIR-18-0518","article-title":"GM-CSF Promotes Antitumor Immunity by Inducing Th9 Cell Responses","volume":"7","author":"Kim","year":"2019","journal-title":"Cancer Immunol. Res"},{"issue":"1","key":"10.1016\/j.smim.2026.102026_bib56","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41467-017-00468-w","article-title":"Selective degradation of PU.1 during autophagy represses the differentiation and antitumour activity of T(H)9 cells","volume":"8","author":"Rivera Vargas","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2026.102026_bib57","doi-asserted-by":"crossref","first-page":"12368","DOI":"10.1038\/ncomms12368","article-title":"Dectin-1-activated dendritic cells trigger potent antitumour immunity through the induction of Th9 cells","volume":"7","author":"Zhao","year":"2016","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.smim.2026.102026_bib58","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00262-014-1557-4","article-title":"Murine Th9 cells promote the survival of myeloid dendritic cells in cancer immunotherapy","volume":"63","author":"Park","year":"2014","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.smim.2026.102026_bib59","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/s41467-019-09401-9","article-title":"IL-4 together with IL-1\u03b2 induces antitumor Th9 cell differentiation in the absence of TGF-\u03b2 signaling","volume":"10","author":"Xue","year":"2019","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.smim.2026.102026_bib60","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/cmi.2015.88","article-title":"Inhibition of squamous cancer growth in a mouse model by Staphylococcal enterotoxin B-triggered Th9 cell expansion","volume":"14","author":"Miao","year":"2017","journal-title":"Cell Mol. Immunol."},{"issue":"8","key":"10.1016\/j.smim.2026.102026_bib61","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/jso.23930","article-title":"IL-9 inhibits HTB-72 melanoma cell growth through upregulation of p21 and TRAIL","volume":"111","author":"Fang","year":"2015","journal-title":"J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.smim.2026.102026_bib62","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003459","article-title":"CD4 T cell-intrinsic STING signaling controls the differentiation and effector functions of T(H)1 and T(H)9 cells","volume":"10","author":"Benoit-Lizon","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.smim.2026.102026_bib63","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.jaci.2018.06.036","article-title":"Human T(H)9 differentiation is dependent on signal transducer and activator of transcription (STAT) 3 to restrain STAT1-mediated inhibition","volume":"143","author":"Zhang","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.smim.2026.102026_bib64","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/icb.2010.53","article-title":"Regulation of human Th9 differentiation by type I interferons and IL-21","volume":"88","author":"Wong","year":"2010","journal-title":"Immunol. Cell Biol."},{"issue":"9","key":"10.1016\/j.smim.2026.102026_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107531","article-title":"IL-24 is the key effector of Th9 cell-mediated tumor immunotherapy","volume":"26","author":"Chen","year":"2023","journal-title":"iScience"},{"issue":"2","key":"10.1016\/j.smim.2026.102026_bib66","first-page":"98","article-title":"The distribution of secondary growths in cancer of the breast. 1889","volume":"8","author":"Paget","year":"1989","journal-title":"Cancer Metastas. Rev."},{"issue":"16","key":"10.1016\/j.smim.2026.102026_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.cub.2020.06.081","article-title":"The tumor microenvironment","volume":"30","author":"Anderson","year":"2020","journal-title":"Curr. Biol."},{"issue":"12","key":"10.1016\/j.smim.2026.102026_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/ph17121663","article-title":"Visualizing the Tumor Microenvironment: Molecular Imaging Probes Target Extracellular Matrix, Vascular Networks, and Immunosuppressive Cells","volume":"17","author":"Chan","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"9","key":"10.1016\/j.smim.2026.102026_bib69","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41419-023-06110-6","article-title":"Stromal cells in the tumor microenvironment: accomplices of tumor progression?","volume":"14","author":"Zhao","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.smim.2026.102026_bib70","article-title":"Immunocytes in the tumor microenvironment: recent updates and interconnections","volume":"16","author":"Yu","year":"2025","journal-title":"Front Immunol."},{"issue":"6","key":"10.1016\/j.smim.2026.102026_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110796","article-title":"Lipogenesis mediated by OGR1 regulates metabolic adaptation to acid stress in cancer cells via autophagy","volume":"39","author":"Pillai","year":"2022","journal-title":"Cell Rep."},{"issue":"6","key":"10.1016\/j.smim.2026.102026_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.188984","article-title":"Dietary fat and lipid metabolism in the tumor microenvironment","volume":"1878","author":"Goswami","year":"2023","journal-title":"Biochim Biophys. Acta Rev. Cancer"},{"issue":"14","key":"10.1016\/j.smim.2026.102026_bib73","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1111\/febs.70081","article-title":"The influence of fatty acid metabolism on T cell function in lung cancer","volume":"292","author":"Petiti","year":"2025","journal-title":"Febs J."},{"issue":"1","key":"10.1016\/j.smim.2026.102026_bib74","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41698-022-00272-w","article-title":"Tumor microenvironment heterogeneity an important mediator of prostate cancer progression and therapeutic resistance","volume":"6","author":"Ge","year":"2022","journal-title":"NPJ Precis Oncol."},{"issue":"7","key":"10.1016\/j.smim.2026.102026_bib75","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.7150\/ijbs.72534","article-title":"Tumor heterogeneity reshapes the tumor microenvironment to influence drug resistance","volume":"18","author":"Zhang","year":"2022","journal-title":"Int J. Biol. Sci."},{"issue":"17","key":"10.1016\/j.smim.2026.102026_bib76","doi-asserted-by":"crossref","first-page":"9630","DOI":"10.1073\/pnas.181341498","article-title":"HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation","volume":"98","author":"Yu","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.smim.2026.102026_bib77","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.celrep.2017.01.051","article-title":"The mTOR and PP2A Pathways Regulate PHD2 Phosphorylation to Fine-Tune HIF1\u03b1 Levels and Colorectal Cancer Cell Survival under Hypoxia","volume":"18","author":"Di Conza","year":"2017","journal-title":"Cell Rep."},{"issue":"5516","key":"10.1016\/j.smim.2026.102026_bib78","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1126\/science.1059817","article-title":"Jr., HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing","volume":"292","author":"Ivan","year":"2001","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.smim.2026.102026_bib79","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc3183","article-title":"HIF1\u03b1 and HIF2\u03b1: sibling rivalry in hypoxic tumour growth and progression","volume":"12","author":"Keith","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.smim.2026.102026_bib80","doi-asserted-by":"crossref","first-page":"63","DOI":"10.17305\/bjbms.2022.8013","article-title":"Amphiregulin\/epidermal growth factor receptor\/hypoxia-inducible factor-1\u03b1 pathway regulates T helper 9 and T cytotoxic 9 cell response in adult patients with infectious mononucleosis","volume":"23","author":"Li","year":"2023","journal-title":"Biomol. Biomed."},{"issue":"7","key":"10.1016\/j.smim.2026.102026_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2023.119524","article-title":"Cbx4 governs HIF-1\u03b1 to involve in Th9 cell differentiation promoting asthma by its SUMO E3 ligase activity","volume":"1870","author":"Huang","year":"2023","journal-title":"Biochim Biophys. Acta Mol. Cell Res"},{"issue":"5652","key":"10.1016\/j.smim.2026.102026_bib82","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1126\/science.1088805","article-title":"Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1alpha","volume":"302","author":"Hagen","year":"2003","journal-title":"Science"},{"issue":"14","key":"10.1016\/j.smim.2026.102026_bib83","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1089\/ars.2012.4979","article-title":"The key role of nitric oxide in hypoxia: hypoxic vasodilation and energy supply-demand matching","volume":"19","author":"Umbrello","year":"2013","journal-title":"Antioxid. Redox Signal"},{"issue":"5","key":"10.1016\/j.smim.2026.102026_bib84","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.cell.2011.07.033","article-title":"Control of T(H)17\/T(reg) balance by hypoxia-inducible factor 1","volume":"146","author":"Dang","year":"2011","journal-title":"Cell"},{"issue":"22","key":"10.1016\/j.smim.2026.102026_bib85","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1073\/pnas.1100667108","article-title":"Regulation of type 17 helper T-cell function by nitric oxide during inflammation","volume":"108","author":"Niedbala","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.smim.2026.102026_bib86","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.1038\/ncomms5575","article-title":"Nitric oxide enhances Th9 cell differentiation and airway inflammation","volume":"5","author":"Niedbala","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.smim.2026.102026_bib87","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.3389\/fimmu.2019.01120","article-title":"ATP Triggers Human Th9 Cell Differentiation via Nitric Oxide-Mediated mTOR-HIF1\u03b1 Pathway","volume":"10","author":"Roy","year":"2019","journal-title":"Front Immunol."},{"key":"10.1016\/j.smim.2026.102026_bib88","first-page":"508","article-title":"Enhancement of T cell infiltration via tumor-targeted Th9 cell delivery improves the efficacy of antitumor immunotherapy of solid tumors","volume":"23","author":"Chen","year":"2023","journal-title":"Bioact. Mater."},{"issue":"1","key":"10.1016\/j.smim.2026.102026_bib89","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s40164-024-00520-8","article-title":"Combination of percutaneous thermal ablation and adoptive Th9 cell transfer therapy against non-small cell lung cancer","volume":"13","author":"Pan","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.smim.2026.102026_bib90","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nbt.4086","article-title":"IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor","volume":"36","author":"Adachi","year":"2018","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.smim.2026.102026_bib91","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"Dagogo-Jack","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.smim.2026.102026_bib92","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12123716","article-title":"Impact of the Tumor Microenvironment on Tumor Heterogeneity and Consequences for Cancer Cell Plasticity and Stemness","volume":"12","author":"Hass","year":"2020","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.smim.2026.102026_bib93","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-011522","article-title":"Go to the scene: T(H)9 cells superior migration ability to the lungs explains their exceptional anticancer efficacy","volume":"13","author":"Xu","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"11","key":"10.1016\/j.smim.2026.102026_bib94","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.4049\/jimmunol.2000383","article-title":"IL-9 Abrogates the Metastatic Potential of Breast Cancer by Controlling Extracellular Matrix Remodeling and Cellular Contractility","volume":"206","author":"Das","year":"2021","journal-title":"J. Immunol."},{"issue":"500","key":"10.1016\/j.smim.2026.102026_bib95","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aak9741","article-title":"Foxo1 and Foxp1 play opposing roles in regulating the differentiation and antitumor activity of T(H)9 cells programmed by IL-7","volume":"10","author":"Bi","year":"2017","journal-title":"Sci. Signal"},{"issue":"12","key":"10.1016\/j.smim.2026.102026_bib96","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1084\/jem.20170041","article-title":"Specifically differentiated T cell subset promotes tumor immunity over fatal immunity","volume":"214","author":"Ramadan","year":"2017","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.smim.2026.102026_bib97","article-title":"Interleukin-35 Suppresses Interleukin-9-Secreting CD4(+) T Cell Activity in Patients With Hepatitis B-Related Hepatocellular Carcinoma","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol."},{"issue":"10","key":"10.1016\/j.smim.2026.102026_bib98","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/ni.2390","article-title":"OX40 signaling favors the induction of T(H)9 cells and airway inflammation","volume":"13","author":"Xiao","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.smim.2026.102026_bib99","doi-asserted-by":"crossref","first-page":"8266","DOI":"10.1038\/ncomms9266","article-title":"GITR subverts Foxp3(+) Tregs to boost Th9 immunity through regulation of histone acetylation","volume":"6","author":"Xiao","year":"2015","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.smim.2026.102026_bib100","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/s41385-018-0122-4","article-title":"A role for BATF3 in T(H)9 differentiation and T-cell-driven mucosal pathologies","volume":"12","author":"Tsuda","year":"2019","journal-title":"Mucosal Immunol."},{"issue":"11","key":"10.1016\/j.smim.2026.102026_bib101","doi-asserted-by":"crossref","first-page":"95","DOI":"10.15698\/cst2023.11.291","article-title":"STING-driven activation of T cells: relevance for the adoptive cell therapy of cancer","volume":"7","author":"Richter","year":"2023","journal-title":"Cell Stress"},{"issue":"1","key":"10.1016\/j.smim.2026.102026_bib102","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12943-019-1087-y","article-title":"STING: a master regulator in the cancer-immunity cycle","volume":"18","author":"Zhu","year":"2019","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.smim.2026.102026_bib103","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.immuni.2021.04.019","article-title":"The inhibitory receptor TIM-3 limits activation of the cGAS-STING pathway in intra-tumoral dendritic cells by suppressing extracellular DNA uptake","volume":"54","author":"de Mingo Pulido","year":"2021","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.smim.2026.102026_bib104","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","article-title":"STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors","volume":"41","author":"Woo","year":"2014","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.smim.2026.102026_bib105","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200844","article-title":"STING agonist promotes CAR T cell trafficking and persistence in breast cancer","volume":"218","author":"Xu","year":"2021","journal-title":"J. Exp. Med"},{"issue":"22","key":"10.1016\/j.smim.2026.102026_bib106","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.120638","article-title":"A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1-insensitive models of triple-negative breast cancer","volume":"3","author":"Cheng","year":"2018","journal-title":"JCI Insight"},{"issue":"11","key":"10.1016\/j.smim.2026.102026_bib107","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13112748","article-title":"EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance","volume":"13","author":"Uribe","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.smim.2026.102026_bib108","article-title":"The role of epidermal growth factor receptor in cancer metastasis and microenvironment","author":"Sasaki","year":"2013","journal-title":"Biomed. Res Int 2013"},{"issue":"4","key":"10.1016\/j.smim.2026.102026_bib109","doi-asserted-by":"crossref","DOI":"10.3390\/biom13040670","article-title":"The Emerging Role of IL-9 in the Anticancer Effects of Anti-PD-1 Therapy","volume":"13","author":"Vinokurova","year":"2023","journal-title":"Biomolecules"},{"issue":"12","key":"10.1016\/j.smim.2026.102026_bib110","article-title":"CD97 maintains tumorigenicity of glioblastoma stem cells via mTORC2 signaling and is targeted by CAR Th9 cells","volume":"5","author":"Zhou","year":"2024","journal-title":"Cell Rep. Med"},{"issue":"9","key":"10.1016\/j.smim.2026.102026_bib111","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1038\/s41590-025-02235-2","article-title":"Loss of YTHDF2 enhances Th9 programming and CAR-Th9 cell antitumor efficacy","volume":"26","author":"Xiao","year":"2025","journal-title":"Nat. Immunol."},{"issue":"11","key":"10.1016\/j.smim.2026.102026_bib112","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/s41423-024-01209-y","article-title":"Fatty acid metabolism constrains Th9 cell differentiation and antitumor immunity via the modulation of retinoic acid receptor signaling","volume":"21","author":"Nakajima","year":"2024","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.smim.2026.102026_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108411","article-title":"Lipid metabolism in Th17 cell function","volume":"245","author":"Kanno","year":"2023","journal-title":"Pharm. Ther."},{"issue":"9","key":"10.1016\/j.smim.2026.102026_bib114","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1093\/annonc\/mdv209","article-title":"Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?","volume":"26","author":"Apetoh","year":"2015","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.smim.2026.102026_bib115","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2014.998538","article-title":"Consensus nomenclature for CD8(+) T cell phenotypes in cancer","volume":"4","author":"Apetoh","year":"2015","journal-title":"Oncoimmunology"}],"container-title":["Seminars in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532326000138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532326000138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:38:37Z","timestamp":1792787917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044532326000138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":115,"alternative-id":["S1044532326000138"],"URL":"https:\/\/doi.org\/10.1016\/j.smim.2026.102026","relation":{},"ISSN":["1044-5323"],"issn-type":[{"value":"1044-5323","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel therapeutic strategies leveraging TH9 cell anticancer functions","name":"articletitle","label":"Article Title"},{"value":"Seminars in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smim.2026.102026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102026"}}